Article

Metabolic remodeling by the PD-L1 inhibitor BMS-202 significantly inhibits cell malignancy in human glioblastoma

2023-09-18

Abstract excerpt

Recent crystallographic studies have shown that BMS-202, a small molecule compound with a methoxy-1-pyridine chemical structure, interacts well with PD-L1 dimerization. However, its roles and mechanisms of BMS-202 in glioma have not yet been reported. The aims of this work were to study BMS-202 antitumor activity and its underlying mechanisms in glioma. In the study, the multi-omics and bioinformatics tools, a ser...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6d53bec5-57f3-5cf4-9698-e9f763547b3f
DOI: 10.21203/rs.3.rs-3247198/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Metabolic remodeling by the PD-L1 inhibitor BMS-202 significantly inhibits cell malignancy in human glioblastomaDOI 10.21203/rs.3.rs-3247198/v1Read

Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma.Semantic proximity Read

RPL22L1, a Novel Candidate Oncogene Promotes Temozolomide Resistance by Activating STAT3 in GlioblastomaSemantic proximity Read

LDHA-regulated tumor-macrophage symbiosis promotes glioblastoma progressionSemantic proximity Read

FXYD5 promotes the growth of glioblastoma by targeting the PI3K/AKT/ACSL4 signaling axisSemantic proximity Read

IGF2 associated PI3K signaling shapes temozolomide sensitivity in glioblastomaSemantic proximity Read

Long noncoding RNA LINC01842 enhances disulfidptosis resistance and promotes glioma progression via IQGAP1Semantic proximity Read

Construction of a prognostic model using lactylation-related genes for predicting the prognosis of glioma patients.Semantic proximity Read

Effects of Combination Therapy of a CDK4/6 and MEK Inhibitor in Diffuse Midline Glioma Preclinical ModelsSemantic proximity Read

Machine learning-driven discovery of potent isocitrate dehydrogenase 1 mutant inhibitors from ultralarge ligand libraries for targeting malignant glioma.Semantic proximity Read

EPIC-1042 as a potent PTRF/Cavin1–caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastomaSemantic proximity Read

RETRACTED: Pharmacological blockade of NMUR2 suppresses the growth of human glioma cells in vivo through the inhibition of STAT5-mediated transcriptional activation of cell-cycle associated genesSemantic proximity Read

A novel small-molecule activator of Sirtuin-1 induces autophagic cell death/mitophagy as a potential therapeutic strategy in glioblastomaSemantic proximity Read